Sweet Potato (Ipomoea Batatas): An Excellent Nutraceutical in the Management of Type 2 Diabetes
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 3 | Views: 379 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Research Paper | Pharmaceutical Science | India | Volume 11 Issue 8, August 2022 | Popularity: 5.1 / 10


     

Sweet Potato (Ipomoea Batatas): An Excellent Nutraceutical in the Management of Type 2 Diabetes

Balusupati Anjali Venkata Lakshmi


Abstract: Ipomoea batatas (Sweet Potato) are known to be high in fiber and have a low glycemic index, which results in a less immediate impact on blood glucose levels. This can help individuals with diabetes control their blood sugar. In this article I discuss about the mechanism involved in sweet potato to control the blood sugar levels, quantity of sweetpotato to be consumed by people with diabetes and risks of overconsumption of sweet potato.


Keywords: Ipomoea batatas (Sweet Potato), low glycemic index, blood glucose levels, diabetes


Edition: Volume 11 Issue 8, August 2022


Pages: 254 - 256


DOI: https://www.doi.org/10.21275/SR22731181329


Please Disable the Pop-Up Blocker of Web Browser

Verification Code will appear in 2 Seconds ... Wait



Text copied to Clipboard!
Balusupati Anjali Venkata Lakshmi, "Sweet Potato (Ipomoea Batatas): An Excellent Nutraceutical in the Management of Type 2 Diabetes", International Journal of Science and Research (IJSR), Volume 11 Issue 8, August 2022, pp. 254-256, https://www.ijsr.net/getabstract.php?paperid=SR22731181329, DOI: https://www.doi.org/10.21275/SR22731181329

Top